Related Experiment Video

Updated: May 8, 2026

One Minute, Sub-One-Watt Photothermal Tumor Ablation Using Porphysomes, Intrinsic Multifunctional Nanovesicles
09:51

One Minute, Sub-One-Watt Photothermal Tumor Ablation Using Porphysomes, Intrinsic Multifunctional Nanovesicles

Published on: September 18, 2013

Engineering pyroptotic vesicles as personalized cancer vaccines

Zhaoting Li1,2,3,4, Yixin Wang1,2,3, Fanyi Mo1

  • 1Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin-Madison, Madison, WI, USA.

Nature Nanotechnology
|May 16, 2025
PubMed

Insights

Researchers developed a novel pyroptotic vesicle vaccine platform to combat cancer recurrence. This personalized cancer vaccine effectively stimulates immune responses, outperforming existing methods in preclinical models.

Area of Science:

  • Biotechnology
  • Immunology
  • Oncology

Background:

  • Current tumour vaccines face limitations due to individual variability, tumour complexity, and adverse effects.
  • Personalized cancer vaccines are needed to overcome these challenges and improve therapeutic outcomes.
  • Extracellular vesicles (EVs) are emerging as promising platforms for drug delivery and immunotherapy.

Purpose of the Study:

  • To engineer pyroptotic vesicles (PVs) as a novel tumour vaccine platform.
  • To evaluate the efficacy of PV-based vaccines in preventing post-surgical tumour recurrence and metastasis.
  • To investigate the underlying immune mechanisms of PV-based cancer immunotherapy.

Main Methods:

  • Pyroptotic vesicles were extracted from pyroptotic tumour cells.
  • PVs were loaded into a biocompatible hydrogel for post-surgical implantation.
  • The efficacy of PV-based vaccines was assessed in post-surgical mouse models of cancer.
  • Immune responses, including dendritic cell and T cell activation, were analyzed.

Main Results:

  • Pyroptotic vesicles demonstrated potent tumour antigen presentation and immune stimulation.
  • PV-based vaccines significantly inhibited tumour recurrence and metastasis compared to exosome- and apoptotic body-based vaccines.
  • The PV-based vaccine elicited robust antigen-specific dendritic cell and T cell responses against both model and neoantigens.
  • The platform showed potential for tailoring immune responses for individual cancer patients.

Conclusions:

  • Pyroptotic vesicles represent a promising and adaptable platform for developing personalized cancer vaccines.
  • PV-based vaccines offer a strategy to overcome current limitations in cancer immunotherapy.
  • This approach holds potential for preventing tumour recurrence and treating individual cancer patients effectively.

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

Related Concept Videos

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.